Neoadjuvant Chemotherapy or Upfront Surgery in Advanced Ovarian Cancer?

A pooled analysis of two randomized trials found that neoadjuvant chemotherapy and upfront debulking surgery yield similar outcomes in patients with advanced tubo-ovarian cancer, except in some settings.

Source: CancerNetwork - November 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news